Joseph Shulman serves as Executive at RHYTHM PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Joseph Shulman has executed 56 insider transactions totaling $14.0M, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 11, 2023 involved exercising options for 1,563 shares valued at $0.
Joseph Shulman currently holds 8,509 shares of RHYTHM PHARMACEUTICALS, INC. (RYTM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joseph Shulman has been a net seller of RYTM stock. They have purchased $0 and sold $14.0M worth of shares.
Joseph Shulman's most recent insider trade was on Feb 11, 2023, when they sold 1,563 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $27.66 |
| Discretionary |
| Feb 9, 2023 | RYTM | $0 | Option Exercise | 2,657 | $N/A | Discretionary |
| Feb 9, 2023 | RYTM | $25.6K | Sale | 931 | $27.51 | Discretionary |
| Feb 15, 2022 | RYTM | $3.4K | Sale | 557 | $6.10 | Discretionary |
| Feb 11, 2022 | RYTM | $0 | Option Exercise | 1,563 | $N/A | Discretionary |